When it comes to Hexa Hydrocannabinol (HHC) research, little exists. Both natural and manufactured cannabinoids, on the other hand, have been discovered to slow tumor growth in a number of animal studies. A research paper in particular looked at the angiogenic effects of several hexahydrocannabinol analogs to see if they might be used in cancer treatments.
In the abstract, they state the following:
Both natural and synthetic cannabinoids have been shown to suppress the growth of tumor cells in culture and in animal models by affecting key signaling pathways including angiogenesis, a pivotal step in tumor growth, invasion, and metastasis. In our search for cannabinoid-like anticancer agents devoid of psychoactive side effects, we synthesized and evaluated the anti-angiogenic effects of a novel series of hexahydrocannabinol analogs.
Dr. Scialdone, PH.D presented his research to CanMed 2017 on the topic, and the video can be viewed below.
More studies are surely underway, and we’ll post the latest updates to this blog post once the findings are made publicly viewable. We encourage you to reach out and contact us if you know more before this page is published.